Piloting Pathways With Lung Cancer Patients

Status Completed

Clinical Trial Summary

The purpose of this research is to determine the feasibility of a new supportive intervention, called Pathways, for patients with advanced stage and metastatic lung cancer.

Clinical Trial Description

In this study, investigators will first test the Pathways procedures with 6 patients to identify any improvements that need to be made. Then, investigators will test the feasibility of the Pathways intervention with 20 patients who are undergoing cancer treatment for advanced stage or metastatic lung cancer. Pathways is designed to help patients set and pursue personal goals during lung cancer treatment. In this study, investigators want to see if they can recruit patients with lung cancer who are being treated at the University of Kentucky Markey Cancer Center to participate in the Pathways intervention. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04161157
Study type	Interventional
Source	University of Kentucky
Contact
Status	Completed
Phase	N/A
Start date	January 13, 2020
Completion date	August 3, 2022

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03177291` - Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC	Phase 1
Recruiting	`NCT05846594` - A Study to Evaluate the Impact of Liquid Biopsy in Participants With a Clinical Diagnosis of Advanced Cancer	Phase 4
Not yet recruiting	`NCT03514329` - Vapor Ablation for Localized Cancer Lesions	N/A
Recruiting	`NCT05502913` - Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer	Phase 2
Recruiting	`NCT06060613` - Safety and Efficacy of OBX-115 in Advanced Solid Tumors	Phase 1/Phase 2
Active, not recruiting	`NCT00986661` - A Study to Assess PV-10 Chemoablation of Cancer of the Liver	Phase 1
Recruiting	`NCT05609578` - Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation	Phase 2
Completed	`NCT01543672` - Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously	Phase 1/Phase 2
Completed	`NCT03198468` - Vapor Ablation for Localized Cancer Lesions of the Lung (VAPORIZE)	N/A
Recruiting	`NCT06180460` - CALM: Managing Distress in Malignant Brain Cancer	N/A
Completed	`NCT04804137` - Immune Response Under Immunotherapy in Metastatic NSCLC: Sputum, Blood Samples and Microbioata Study
Recruiting	`NCT06343402` - Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer	Phase 1
Recruiting	`NCT04940325` - Datopotamab (DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer	Phase 2
Active, not recruiting	`NCT05241873` - (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations	Phase 1/Phase 2
Recruiting	`NCT05256290` - Phase 1/2 Study of BDTX-1535 in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations	Phase 1/Phase 2
Completed	`NCT05908799` - Emulation of the KEYNOTE-189 Trial Using Electronic Health Records
Active, not recruiting	`NCT03867175` - Immunotherapy With or Without SBRT in Patients With Stage IV Non-small Cell Lung Cancer	Phase 3
Recruiting	`NCT04708483` - DCE-CT of Thoracic Tumors as an Early Biomarker for Treatment Monitoring in Comparison With Morphologic Criteria	N/A
Completed	`NCT01307501` - Safety and Efficacy of Cryoablation for Metastatic Lung Tumors	N/A
Recruiting	`NCT03143322` - Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases	N/A